736 results on '"van Gilst, Wiek H."'
Search Results
2. Predictors and outcomes of heart failure with mid‐range ejection fraction
3. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
4. The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
5. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction
6. Genome-wide association study identifies eight loci associated with blood pressure
7. Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance
8. Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
9. LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes
10. Pectins from various sources inhibit galectin-3-related cardiac fibrosis
11. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation
12. Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19: A Multicenter Cohort Study
13. Activation of liver X receptor-α reduces activation of the renal and cardiac renin–angiotensin–aldosterone system
14. Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
15. Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)
16. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects
17. Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin
18. Telomere length and psychological well-being in patients with chronic heart failure
19. The effects of polymorphisms in genes from the renin–angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context
20. Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure
21. Statins in the treatment of chronic heart failure: a systematic review
22. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27
23. The changing face of heart failure: are we really making progress?
24. Cyclical stretch induces structural changes in atrial myocytes
25. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
26. Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia
27. Protective Effects of Erythropoietin in Cardiac Ischemia: From Bench to Bedside
28. Seventy-five genetic loci influencing the human red blood cell
29. Genome-wide meta-analysis of common variant differences between men and women
30. The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing
31. Plasma renin and outcome in the community: data from PREVEND
32. Regulation of the (pro)renin–renin receptor in cardiac remodelling
33. DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure
34. Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load
35. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
36. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study
37. Vitamin D status and outcomes in heart failure patients
38. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation
39. A single dose of erythropoietin in ST-elevation myocardial infarction
40. Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo
41. The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions
42. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure
43. Bone marrow dysfunction in chronic heart failure patients
44. Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure
45. Left atrial pressure reduction for mitral stenosis reverses left atrial direction-dependent conduction abnormalities
46. Galectin-3: a novel mediator of heart failure development and progression
47. Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function
48. Telomere biology in cardiovascular disease: the TERC−/− mouse as a model for heart failure and ageing
49. Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats
50. Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.